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Benzo[b]thiophenesulphonamide 1,1-dioxide (BTS) derivatives are strong cytotoxic agents that induce reactive oxygen species
(ROS) overproduction and apoptosis in tumour cells. Although the precise origin of BTS-induced ROS is not known, a clear
correlation between their cytotoxic effect and ability to inhibit a tumour-associated NADH oxidase (tNOX) activity of the plasma
membrane has been described. To analyse the putative implication of tNOX in BTS-induced ROS generation, in this work we have
synthesised and tested a new BTS derivative, the 6-[N-(2-phenylethyl)]benzo[b]thiophenesulphonamide 1,1-dioxide. According to its
high lipophilicity, this compound showed a strong cytotoxic activity against a panel of six human tumour cell lines, including two
human leukaemia (K-562 and CCRF-CEM) and four human solid tumours (HT-29, HTB54, HeLa and MEL-AC). We also tested the
ability of this compound to inhibit the tNOX activity and we found an absolute dependence of this inhibition on the redox state of
the tNOX: while under reducing conditions, that is, 100mM GSH, the drug inhibits strongly the NOX activity with an EC50 of about
0.1nM, under oxidising conditions, there is no effect of the drug or just a slight stimulation of activity.
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Benzo[b]thiophenesulphonamide 1,1-dioxide (BTS) derivatives
have been reported as a new class of potential antineoplastic
agents (Martı ´nez-Merino et al, 2000). These compounds, which
were synthesised and analysed in in vitro antitumour assays on the
basis of theoretic structure–activity COMFA studies of sulphony-
lureas (Martı ´nez-Merino et al, 1995; Gil et al, 1999), induce in
human leukaemia CCRF-CEM cells a typical process of apoptosis
that includes cell shrinkage, phosphatidylserine translocation to
the cell surface, mitochondrial dysfunction, caspase activation,
chromatin condensation and internucleosomal DNA degradation
(Alonso et al, 2003). CCRF-CEM cells start to accumulate reactive
oxygen species (ROS) within minutes after BTS addition, and these
molecules are essential mediators required for the induction of
cytochrome 3 mitochondrial release, caspase-3 activation and cell
death, as revealed by the fact that these events are prevented by
treatment with N-acetyl-cysteine (Alonso et al, 2003). Although the
precise origin of BTS-induced ROS is not known, a clear
correlation between their cytotoxic effect and ability to inhibit
an NADH oxidase (NOX) activity found in the plasma membrane
and conditioned culture medium of CCRF-CEM cells has been
described (Alonso et al, 2001).
ECTO-NOX are cell surface-associated and growth-related
protein oxidases that exhibit two different activities, protein
disulphide-thiol interchange and hydroquinone (or NADH)
oxidation, that alternate to yield oscillatory patterns (Morre ´ and
Morre ´, 2003). Two forms of ECTO-NOX have been detected in sera
of cancer patients (Wang et al, 2003): a widely distributed
constitutive NOX (CNOX) of the mammalian cell surface that
has a period length of 24min (Sedlak et al, 2001) and is resistant to
inhibition by quinone site inhibitors (Chueh et al, 2002a) like the
vainilloid capsaicin or the antitumour sulphonylurea N-4-(methyl-
phenylsulphonyl)-N0-(4-chlorophenyl)urea (LY181984), and a tu-
mour-associated NOX (tNOX) with a period length of 22min
(Chueh et al, 2002a) that is inhibited by capsaicin (Morre ´ et al,
1997a) or LY181984 (Morre ´ and Reust, 1997b) and is low or absent
from sera of individuals not diagnosed as having cancer (Morre ´
et al, 1997a). The tNOX protein is also specifically inhibited in
HeLa and human mammary adenocarcinoma cells by ( )-
epigallocatechin-3-gallate (EGCg) (Morre ´ et al, 2000), the principal
catechin of green tea; EGCg also inhibited growth of transformed
cells in culture. Since this action appears to result from an effect on
regulation of cell cycle progression and induction of apoptosis
(Ahmad et al, 1997, 2000, 2002; Gupta et al, 2000) rather than from
an unspecific antioxidant function (Salucci et al, 2002), tNOX
protein has been proposed as the molecular target on cancer cells
to explain their specific inhibition of growth by EGCg (Morre ´ et al,
2000).
The putative implication of tNOX in BTS-induced ROS
generation and the fact that some enzymes related with ROS
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scontrol such as the glutathione reductase and the glutathione
S-transferase present a hydrophobic pocket near their active
site (Karplus and Schulz, 1989; Chern et al, 2000) led us to
synthesise and analyse new derivatives of the benzo[b]thiophene
1,1-dioxide carrying hydrophobic substituents of different length
and grade of flexibility on the sulphonamide group and, in some
cases, a clear correlation between the lipophilicity (logP) and the
cytotoxic effect of these compounds was observed (Villar et al,
2004). Here we describe the synthesis and cytotoxic activity of
6-[N-(2-phenylethyl)]benzo[b]thiophenesulphonamide 1,1-dioxide
(BTS-2), a new BTS derivative with increased flexibility, high
lipophilicity (logP¼2.82) and a predicted low toxicity for its
putative metabolites, and we show its ability to specifically inhibit
the tNOX activity and the absolute dependence of this inhibition
on the redox state of the tNOX.
MATERIALS AND METHODS
Chemistry
Benzo[b]thiophenesulphonamide 1,1-dioxide (BTS-1) was pre-
pared as previously described (Martı ´nez-Merino et al, 2000).
The synthesis of BTS-2 was carried out by the usual methods
described for the synthesis of sulphonamide derivatives (Villar
et al, 2004), that is, through the treatment of the sulphonyl chloride
derivative with ammonia or amines (Scheme 1). The chlorosul-
phonyl derivative was obtained from the 6-aminobenzo[b]thio-
phene 1,1-dioxide by the Meerwein’s method (Meerwein et al,
1957) (treatment of diazonium salts with sulphonyl chloride in the
presence of cuprous chloride), and then treated with phenetyla-
mine to give the BTS-2 (28.1% yield). The previous amine
derivative was produced by reduction of 6-nitrobenzo[b]thiophene
1,1-dioxide, and the last one was synthesised according to
procedures previously published (Challenger and Clapham, 1948)
(60% yield). The oxidation of benzo[b]thiophene was carried out
with 30% hydrogen peroxide.
Cell culture
American Type Culture Collection (ATCC, Manassas, VA) or
European Collection of Cell Cultures (ECACC, Porton Down,
Salisbury, UK) provided human tumour cell lines. Six cell lines
were used: two human leukaemia (K-562 and CCRF-CEM) and
four human solid tumours, one colon carcinoma (HT-29), one lung
carcinoma (HTB54), one cervix epitheloid carcinoma (HeLa) and
one melanoma (MEL-AC). MEL-AC cells were kindly provided by
Dr Natalia Lo ´pez-Moratalla (Universidad de Navarra, Pamplona,
Spain). Human lung fibroblasts (HLFs) were kindly provided by
Dr Markus Nabholzs (ISREC, Epalinges, Switzerland). Cells were
grown in RPMI 1640 medium (Life Technologies, Barcelona,
Spain) supplemented with 10% fetal calf serum, 2mML -glutamine,
100Uml
 1 penicillin, 100mgml
 1 streptomycin and 10mM HEPES
buffer (pH 7.4).
Cytotoxicity assay
The cytotoxic effect of each substance was tested at five different
doses between 0.01 and 100mM. Each substance was initially
dissolved in DMSO at a concentration of 0.1 M, and serial dilutions
were prepared using culture medium. The plates with cells from
the different lines, to which media containing the substance under
test were added, were incubated for 72h at 371C in a humidified
atmosphere containing 5% CO2. Cytotoxicity was then determined
by a colorimetric microassay based on the use of MTT (Mosmann,
1983). Results are expressed as GI50, concentration that reduced by
50% the growth of treated cells with respect to untreated controls.
Protein isolation and determination
Cell membrane NOX activity (Cellex) was released in soluble form
from HeLa cells (whole cells) as previously described (Del Castillo-
Olivares et al, 1998).
Proteins were determined by the bicinchoninic acid/copper
assay (Smith et al, 1985) obtained from Pierce using bovine serum
albumin as standard.
NADH oxidase activity measurement
NADH oxidase activity was determined as the disappearance of
NADH at 340nm in a reaction mixture containing 25mM Tris-Mes
buffer (pH 7.2), 1mM KCN to inhibit any potential mitochondrial
oxidase activity and 150mM NADH at 371C and continuous stirring
(Wang et al, 2003). Assays were initiated by addition of NADH.
Absorbance was recorded for 1min after adding NADH and a
millimolar extinction coefficient of 6.22 was used to determine
specific activity.
RESULTS
The cytotoxic activity of BTS-1 and BTS-2 (Figure 1) was tested
against a panel of human tumour cell lines, including cervix
epitheloid carcinoma (HeLa), lymphocytic leukaemia (CCRF-
CEM), myelocytic leukaemia (K-562), melanoma (MEL-AC),
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Figure 1 Structure of BTS used in this work.
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shuman colon carcinoma (HT-29) and lung carcinoma (HTB-54),
and also against normal HLFs growing in culture. Cells
were grown in RPMI 1640 medium (Life Technologies) supple-
mented with 10% fetal calf serum, 2mML -glutamine, 100uml
 1
penicillin, 100mgml
 1 streptomycin and 10mM HEPES buffer
(pH 7.4). The cytotoxic effect of each substance was tested
at five different doses between 0.01 and 100mM. The plates with
cells from the different lines, to which media containing
the substance under test were added, were incubated for
3 days and cell survival was then determined by an MTT-based
colorimetric assay (Mosmann, 1983). Results are expressed
as GI50, concentration that reduced by 50% the growth of treated
cells with respect to untreated controls. As shown in Table 1,
growth of every cell line was clearly affected by the tested
compounds, and is worth noting that according to its higher
lipophilicity, BTS-2 was more cytotoxic against each one of the
tested cell lines than the lead compound (BTS-1). Moreover,
activity of BTS-2 was in the same order of magnitude as
commercial doxorubicin against K-562 tumour cells and normal
lung fibroblasts growing in culture. Figure 2 shows curves with the
original data from which the GI50 values for BTS-1 and BTS-2 were
calculated.
It has been previously shown that BTS-1 and some related
diarylsulphonylureas (DSU) are able to inhibit a tumour cell-
specific NOX activity present in the membrane of CCRF-CEM cells
(Alonso et al, 2001). As we had said before, until now tNOX
activity is the only cell target proposed to explain the specific
inhibition of growth of cancer cells induced by the antitumour
sulphonylurea LY181984 (Morre ´ et al, 1995a,b) and the green tea
catechin EGCg (Morre ´ et al, 2000). Since BTS-2 was designed on
the basis of experimental results obtained with BTS-1 and other
BTS that are structurally related with DSU, we decided to further
analyse the action of BTS-2 on tNOX activity. For these purpose,
we performed standard NOX assays using either a preparation
released at pH 5 from HeLa cells obtained from Cellex Biosciences
Table 1 Cytotoxic activities (GI50, mM inhibition of cell growth) against tumor cell lines and lipophilicity
Compound HeLa CCRF-CEM K-562 MEL-AC HT-29 HTB-54 HLF logP
BTS-1 2.2 2.86 29.41 7.14 8.55 5.89 5.04  0.03
BTS-2 0.24 0.1 0.07 0.81 2.52 0.23 0.04 2.82
Dx 0.02 0.03 0.02 0.01 ND ND 0.01 ND
Dx: doxorubicin; ND: not determined.
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Figure 2 Determination of the cytotoxic effect of (A) BTS-1 and (B) BTS-2. Cells were incubated in the presence of every compound at the indicated
concentration for 72h. Cytotoxicity was then determined by a colorimetric microassay based on the use of MTT (Mosmann, 1983). Values represent
means7s.d. derived from three independent experiments each performed in quadruplicate.
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Figure 3 Dose-dependent inhibition by BTS-2 of NOX activity of (A)
HeLa cells and (B) Cellex preparations in the presence of 100mM GSH
(solid symbols). Assay was based on spectrophotometric measurement of
NADH disappearance at 340nm. The compound was dissolved in ethanol
and compared to solvent alone (open symbols).
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s(Minneapolis, USA), which is a mixture of NOXs (Del Castillo-
Olivares et al, 1998), or from intact HeLa cells. NADH
is an impermeant substrate and, therefore, can be used to measure
cell surface NADH activity with whole cells. Results with
isolated plasma membrane and with whole cells were similar.
NADH oxidase activity was determined as the disappearance
of NADH measured at 340nm. The compound was dissolved in
ethanol and compared to solvent alone. As shown in Figure 3, in
the presence of reducing conditions, that is, 100mM GSH, the
drug inhibited strongly the NOX activity of both the intact HeLa
(Figure 3A) and Cellex (Figure 3B) preparations with an EC50 of
about 0.1nM. The figure also shows small stimulations by ethanol
(chemical hormesis) that are not unusual for the cell surface
NOX activities (Morre ´, 2000). Although both the Cellex and
intact HeLa preparations contain a cancer-specific and drug-
inhibited tNOX and a constitutive and drug-resistant NOX,
the data show that only tNOX is being inhibited, and indicate
that this inhibition, which is dose dependent, is almost complete at
0.1mM. Otherwise, the residual NOX activity corresponding to
CNOX would approach zero at the high drug concentration. In
agreement with this, NOX activities of plasma membranes purified
from soybean (Glycine max), which contain only CNOX, were
unaffected by BTS-2 over the concentration range 10
 11–10
 5 M
(N¼4) (not shown).
The effect of the drug on the NOX activity under oxidising
conditions is analysed in Figure 4. As can be seen, when the
oxidising conditions were provided by treatment of HeLa cells with
hydrogen peroxide (Figure 4A), the derivative inhibited only at the
highest concentration of 10mM. Moreover, with Cellex preparations
(Figure 4B), stimulation was recorded at 10mM. As with hydrogen
peroxide, when the assays were performed in the presence of
100mM GSSG (Figure 4C and D), we could see no inhibition of the
NOX activity, only a slight stimulation. Thus, it can be concluded
that while under reducing conditions BTS-2 strongly inhibits
tNOX, under oxidising conditions there is no effect of the drug or
just a slight stimulation of activity. The absolute dependency of
inhibition on redox state of tNOX has also been described with the
antitumour sulphonylureas (Morre ´ et al, 1998).
DISCUSSION
We have previously shown that BTS derivatives are strong
cytotoxic agents that induce ROS overproduction and apoptosis
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Figure 4 Lack of inhibition of the NOX activity by BTS-2 under oxidising conditions (solid symbols). (A) Normal NOX assays performed with intact
HeLa cells in which the preparations were first reduced with 100mM GSH for 10min and then fully oxidised by addition of 0.03% hydrogen peroxide for
10min. (B)A si n( A) but with 50ml of the Cellex preparation. (C)A si n( A) but with assay in the presence of 100mM GSSG. (D)A si n( B) but with assay
in the presence of 100mM GSSG. The compounds were dissolved in ethanol and compared to solvent alone (open symbols). The ethanol concentration
was 0.16% maximum.
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sin tumour cells (Alonso et al, 2003). We have also shown that while
the BTS derivatives that exhibit this cytotoxic activity are able to
inhibit a NOX activity of the plasma membrane of leukaemia
CCRF-CEM cells, those that lack cytotoxic activity also lack this
inhibitory effect (Alonso et al, 2001), thus suggesting that ECTO-
NOX proteins could provide a molecular target for the induction of
ROS production by BTS derivatives. Here we report that BTS-2, a
new BTS derivative with high lipophilicity and improved cytotoxic
activity, specifically inhibits the tNOX activity of HeLa cells, and
we show that this inhibition is dependent on the redox state of
tNOX.
A number of motifs within tNOX, including an NADH binding
site, a quinone binding site and sites for protein disulphide-thiol
interchange, account for the range of its functional activities
(Chueh et al, 2002b). The drug response of tNOX has been studied
extensively with LY181984 (Morre ´ et al, 1998). Activity is inhibited
or stimulated by this sulphonylurea depending on the redox
environment of the protein. Ubiquinone competes with both
LY181984 binding and inhibition of enzymatic activities and so the
drug, like capsaicin (Morre ´ et al, 1995c), EGCg (Morre ´ et al, 2000)
and adriamycin (Morre ´ et al, 1997c), which also inhibit activity, is
considered to occupy the quinone binding site. Interestingly, while
the normal CNOX isoform and tNOX share functional character-
istics, CNOX appears to lack the quinone binding motif EEMTE
(Chueh et al, 2002a), a fact that could explain why both enzymes
differ primarily in their sensitivity to these drugs. Since we show
here that under reducing conditions BTS-2 inhibits strongly the
NOX activity of both intact HeLa cells and Cellex preparations
containing both tNOX and CNOX, while ECTO-NOX activities of
plasma membranes from soybean, which contain only CNOX, are
unaffected by this drug, the possibility that BTS derivatives exert
their specific inhibitory action on tNOX activity through binding
to the quinone site should be considered.
It has been described that the tNOX activity can be inhibited by
thiol reagents such as the N-ethyl-maleimide (NEM) (Morre ´ et al,
1995a,b). It has also been reported that compounds carrying the
benzo[b]thiophene 1,1-dioxide nucleus, like BTS-1 and -2, are thiol
reagents (Bordwell et al, 1954). For this reason, it is very
interesting that the C2–C3 dihydro derivative of BTS-1, which
was reported to be inactive both in the cytotoxicity and enzymatic
assays (Alonso et al, 2001), cannot be considered a thiol reagent.
Since this compound and BTS-1 have identical molecular sizes and
capacities to interact through polar groups, hydrogen bonds and/
or hydrophobic interactions with putative receptor sites, activity of
BTS-1 can be attributed to the C2–C3 double bond reactivity. In
agreement with this, the C3-methyl derivative of BTS-1 shows no
cytotoxic activity (Villar et al, 2004), a result that can be attributed
to its impaired reactivity towards thiol groups. Thus, the
possibility that BTS derivatives exert their inhibitory action on
tNOX activity by interacting with cysteines of the active sites for
protein disulphide-thiol interchange should also be considered.
The fact that BTS actions over cell growth are prevented by
previous treatment of the cells with N-acetyl-cysteine (Alonso et al,
2003) and our finding that under oxidising conditions there is no
effect of BTS-2 on the tNOX activity also support this idea.
Interference with DNA and RNA is generally considered to
account for the cytotoxicity of anthracycline antitumour drugs.
However, it has been shown that doxorubicin is cytotoxic even
without entering the cells (Tritton and Yee, 1982), and inhibition
of tNOX activity by doxorubicin (EC50¼0.7nM) has been
described (Morre ´ et al, 1997c; Hedges et al, 2003). Interestingly,
when cell growth is inhibited, redox activities of the plasma
membrane are also inhibited, and thus NOX activity of the plasma
membrane has been suggested as a growth-related doxorubicin
target at the surface of cancer cells (Kim et al, 2002; Hedges et al,
2003). For this reason, the fact that BTS-2 acts in the same order of
magnitude as doxorubicin against K-562 tumour cells and also
against normal HLFs that should have a low or even absent tNOX
activity rises the possibility of additional sites of action for this
drug. Further experiments are required to clarify this fact.
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